3rd March 2025, New Delhi: Akums Drugs & Pharmaceuticals, India’s leading contract development and manufacturing organization (CDMO), has signed a Memorandum of Understanding (MOU) with the National Institute of Food Technology, Entrepreneurship…
Tag: Sanjeev Jain
Akums Drugs Reports 12% EBITDA and 15% PAT Growth in Q3 FY25
New Delhi, February 7, 2025: Akums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, 2024, delivering 12% increase in Adjusted EBITDA on year on…